Benign Prostatic Hyperplasia Treatment Market to Surpass USD 17.6 Billion by 2028 | BlueWeave Consulting
August 03, 2022 11:00 ET
|
BlueWeave Consulting and Research Pvt Ltd
New Delhi, Aug. 03, 2022 (GLOBE NEWSWIRE) -- The rise in benign prostatic hyperplasia prevalence and the expanding worldwide male geriatric population are both important factors driving the growth...